BioSpace News Archive

2019 Total Revenue was $24.9 million, with 2019 Product Sales of $22.8M, and blended product gross margins of 80% for Q4 2019

Rafael Holdings, Inc. reported revenue of $1.2 million and a loss per diluted share of $0.08 for the fiscal quarter ended January 31, 2020.

ElevateBio, a Cambridge-based cell and gene therapy holding company, announced that Kareem Reda has been appointed to the newly created position of Chief Business Officer.

Cigna customers will have access to coronavirus testing, as prescribed by health practitioners, and the company will waive all co-pays or cost-shares to help fight the rapid spread of the virus in the U.S. and for its globally mobile customers..

McKesson Corporation announced the final exchange ratio of 11.4086-for-one in connection with its previously announced offer to its stockholders to exchange their shares of McKesson common stock for shares of PF2 SpinCo, Inc. common stock.

Pacific Biosciences of California, Inc. announced that industry veteran Christian Henry has been appointed to serve as Chairman of its Board of Directors.

Silk Road Medical, Inc. announced that effective as of market open on March 6, 2020, its common stock has been approved for uplisting to the Nasdaq Global Select Market® and will continue trading under its current ticker symbol “SILK”.

Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that it will host a conference call and audio webcast on Thursday, March 12, 2020 at 1:30 pm PT / 4:30 pm ET to report its fourth quarter 2019 financial results and provide a corporate update.

SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today reported 2019 full year financial results and announced product delivery expectations for oral TPOXX® under the HHSO100201800019C contract with the Biomedical Advanced Research and Development Authority (“BARDA”, and “19C BARDA Contract”, also known as the 2018 BARDA Contract)

Synlogic, Inc. announced that the Company will release its fourth quarter and full year 2019 financial results after the market closes on Thursday, March 12, 2020.